Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 84
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07223632 | Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individual Patient | ||
| NCT06803290 | Food Effect Study of VHX-896 in Healthy Volunteers | ||
| NCT02560103 | An Observational Study to Investigate the Effects of Rapid Transmeridian Travel | ||
| NCT02776215 | Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents | ||
| NCT01540500 | Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine | ||
| NCT03373201 | Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia | ||
| NCT04028492 | Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis | ||
| NCT04652882 | Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) | ||
| NCT05361707 | Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances | ||
| NCT04969211 | Bioequivalence Study Between VHX-896 Tablets and Iloperidone Tablets in Healthy Volunteers | ||
| NCT01348100 | Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients | ||
| NCT04856917 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris | ||
| NCT01578057 | Evaluation of the Pharmacodynamic and Pharmacokinetic Interactions of Tasimelteon and Ethanol | ||
| NCT00254202 | Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia | ||
| NCT07221578 | Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder | ||
| NCT00291187 | VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia | ||
| NCT02004041 | Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis | ||
| NCT01402076 | A Study to Assess the Effect Tasimelteon on the Cytochrome P450 3A4 and 2C8 Enzymes in Healthy Subjects | ||
| NCT06961968 | Randomized Withdrawal Study in Patients With Schizophrenia | ||
| NCT04622345 | Safety and Efficacy of VSJ-110 in the Treatment of Allergic Conjunctivitis in Adults With a History of Ocular Allergies | ||
| NCT01919944 | Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P | ||
| NCT06836557 | Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis | ||
| NCT01477619 | Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects | ||
| NCT03619902 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Generalized Pustular Psoriasis | ||
| NCT01428661 | Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder | ||
| NCT04800237 | Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety | ||
| NCT06296966 | A Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye | ||
| NCT03154697 | Development of Clinical Database of Individuals With Smith-Magenis Syndrome and Sleep Disturbances | ||
| NCT04327661 | Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness | ||
| NCT05366855 | Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPP | ||
| NCT02130999 | Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™) | ||
| NCT01495169 | Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients | ||
| NCT06494397 | Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions | ||
| NCT06953869 | Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia | ||
| NCT01291511 | Relapse Prevention Study in Patients With Schizophrenia | ||
| NCT04697056 | A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis | ||
| NCT07179055 | An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye | ||
| NCT05648591 | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | ||
| NCT02231008 | Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS | ||
| NCT01271387 | Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment | ||
| NCT06830044 | Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder | ||
| NCT02621385 | Study to Assess the Effect of Multiple Doses of Tradipitant on CYP3A4 Using Midazolam as a Substrate in Healthy Subjects | ||
| NCT02651714 | Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis | ||
| NCT00490945 | Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers | ||
| NCT06323655 | Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects | ||
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | ||
| NCT05572281 | Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers | ||
| NCT05344365 | A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis | ||
| NCT04127058 | Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia | ||
| NCT01430754 | Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder |
